Literature DB >> 28444816

Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.

P Gantner1, L Cuzin2,3,4, C Allavena5, A Cabie6, P Pugliese7, M-A Valantin8,9, F Bani-Sadr10, V Joly11, T Ferry12, I Poizot-Martin13, R Garraffo14, G Peytavin15,16, S Fafi-Kremer1, D Rey17.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28444816     DOI： 10.1111/hiv.12506

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  14 in total

Review 1.  Dolutegravir/Rilpivirine: A Review in HIV-1 Infection.

Authors:  Hannah A Blair
Journal:  Drugs       Date:  2018-11       Impact factor: 11.431

2.  Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus.

Authors:  Lauren Greenberg; Lene Ryom; Bastian Neesgaard; Gilles Wandeler; Therese Staub; Martin Gisinger; Michael Skoll; Huldrych F Günthard; Alexandra Scherrer; Cristina Mussini; Colette Smith; Margaret Johnson; Stéphane De Wit; Coca Necsoi; Christian Pradier; Ferdinand Wit; Clara Lehmann; Antonella d'Arminio Monforte; Jose M Miró; Antonella Castagna; Vincenzo Spagnuolo; Anders Sönnerborg; Matthew Law; Jolie Hutchinson; Nikoloz Chkhartishvili; Natalia Bolokadze; Jan-Christian Wasmuth; Christoph Stephan; Vani Vannappagari; Felipe Rogatto; Josep M Llibre; Claudine Duvivier; Jennifer Hoy; Mark Bloch; Heiner C Bucher; Alexandra Calmy; Alain Volny Anne; Annegret Pelchen-Matthews; Jens D Lundgren; Lars Peters; Loveleen Bansi-Matharu; Amanda Mocroft
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 20.999

3.  Switch from tenofovir disoproxil fumarate combination to dolutegravir with rilpivirine improves parameters of bone health.

Authors:  Grace A McComsey; Sergio Lupo; David Parks; Mónica Coronado Poggio; Joseph De Wet; Lesley P Kahl; Kostas Angelis; Brian Wynne; Kati Vandermeulen; Martin Gartland; Michael Cupo; Michael Aboud
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177

Review 4.  Dolutegravir/rilpivirine for the treatment of HIV-1 infection.

Authors:  Ellen Dowers; Francis Zamora; Lydia Aoun Barakat; Onyema Ogbuagu
Journal:  HIV AIDS (Auckl)       Date:  2018-11-02

Review 5.  HIV evolution and diversity in ART-treated patients.

Authors:  Gert van Zyl; Michael J Bale; Mary F Kearney
Journal:  Retrovirology       Date:  2018-01-30       Impact factor: 4.602

Review 6.  Two's a Company, Three's a Crowd: A Review of Initiating or Switching to a Two-Drug Antiretroviral Regimen in Treatment-Naïve and Treatment-Experienced Patients Living with HIV-1.

Authors:  Melissa Badowski; Sarah E Pérez; David Silva; Andrea Lee
Journal:  Infect Dis Ther       Date:  2020-03-19

Review 7.  Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV.

Authors:  Daniel M Himmel; Eddy Arnold
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-11

8.  Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

Authors:  Clotilde Allavena; Matthieu Hanf; David Rey; Claudine Duvivier; Firouze BaniSadr; Isabelle Poizot-Martin; Christine Jacomet; Pascal Pugliese; Pierre Delobel; Christine Katlama; Véronique Joly; Christian Chidiac; Nathalie Dournon; Dominique Merrien; Thierry May; Jacques Reynes; Amandine Gagneux-Brunon; Catherine Chirouze; Thomas Huleux; André Cabié; François Raffi
Journal:  PLoS One       Date:  2018-09-21       Impact factor: 3.240

9.  Virologic failure and HIV drug resistance on simplified, dolutegravir-based maintenance therapy: Systematic review and meta-analysis.

Authors:  Gilles Wandeler; Marta Buzzi; Nanina Anderegg; Delphine Sculier; Charles Béguelin; Matthias Egger; Alexandra Calmy
Journal:  F1000Res       Date:  2018-08-30

10.  Effectiveness, Safety, and Tolerability of a Switch to Dual Therapy with Dolutegravir Plus Cobicistat-Boosted Darunavir in Treatment-Experienced Patients with Human Immunodeficiency Virus.

Authors:  Sang Ah Lee; Shin Woo Kim; Hyun Ha Chang; Hyejin Jung; Yoonjung Kim; Soyoon Hwang; Sujeong Kim; Han Ki Park; Jong Myung Lee
Journal:  Infect Chemother       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.